Windtree Therapeutics (NASDAQ:WINT – Get Free Report) posted its quarterly earnings results on Monday. The company reported ($20.91) earnings per share for the quarter, missing the consensus estimate of ($8.11) by ($12.80), Zacks reports.
Windtree Therapeutics Trading Up 2.0 %
NASDAQ WINT opened at $11.22 on Wednesday. Windtree Therapeutics has a 12 month low of $2.81 and a 12 month high of $27.00. The stock’s fifty day moving average price is $5.81 and its 200-day moving average price is $5.71. The stock has a market cap of $6.64 million, a P/E ratio of -0.31 and a beta of 0.55.
Windtree Therapeutics Company Profile
Read More
- Five stocks we like better than Windtree Therapeutics
- The 3 Best Fintech Stocks to Buy Now
- Doximity: The ‘Facebook for Doctors’ Surges After Earnings Beat
- How to Invest in Insurance Companies: A Guide
- Value Investing: Unearthing 3 Hidden Gems in Today’s Market
- What Investors Must Know About Over-the-Counter (OTC) Stocks
- Southwest Airlines Rises as Elliott Management Targets Leadership
Receive News & Ratings for Windtree Therapeutics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Windtree Therapeutics and related companies with MarketBeat.com's FREE daily email newsletter.